Mutti M - Search Results

1

ε²-Phages Are Naturally Bred and Have a Vastly Improved Host Range in Staphylococcus aureus over Wild Type Phages.

Sáez Moreno D, Visram Z, Mutti M, Restrepo-Córdoba M, Hartmann S, Kremers AI, Tišáková L, Schertler S, Wittmann J, Kalali B, Monecke S, Ehricht R, Resch G, Corsini L. Sáez Moreno D, et al. Among authors: mutti m. Pharmaceuticals (Basel). 2021 Apr 2;14(4):325. doi: 10.3390/ph14040325. Pharmaceuticals (Basel). 2021. PMID: 33918287 Free PMC article.

2

Robust Approaches for the Production of Active Ingredient and Drug Product for Human Phage Therapy.

Mutti M, Corsini L. Mutti M, et al. Front Microbiol. 2019 Oct 8;10:2289. doi: 10.3389/fmicb.2019.02289. eCollection 2019. Front Microbiol. 2019. PMID: 31649636 Free PMC article. Review.

3

Natural Bred ε²-Phages Have an Improved Host Range and Virulence against Uropathogenic Escherichia coli over Their Ancestor Phages.

Loose M, Sáez Moreno D, Mutti M, Hitzenhammer E, Visram Z, Dippel D, Schertler S, Tišáková LP, Wittmann J, Corsini L, Wagenlehner F. Loose M, et al. Among authors: mutti m. Antibiotics (Basel). 2021 Nov 1;10(11):1337. doi: 10.3390/antibiotics10111337. Antibiotics (Basel). 2021. PMID: 34827275 Free PMC article.

4

Phage activity against Staphylococcus aureus is impaired in plasma and synovial fluid.

Mutti M, Moreno DS, Restrepo-Córdoba M, Visram Z, Resch G, Corsini L. Mutti M, et al. Sci Rep. 2023 Oct 24;13(1):18204. doi: 10.1038/s41598-023-45405-8. Sci Rep. 2023. PMID: 37875544 Free PMC article.

5

A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Mutti M, Ramoni K, Nagy G, Nagy E, Szijártó V. Mutti M, et al. Front Immunol. 2018 Dec 4;9:2770. doi: 10.3389/fimmu.2018.02770. eCollection 2018. Front Immunol. 2018. PMID: 30564230 Free PMC article.

6

Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Mutti M, Sonnevend Á, Pál T, Junttila S, Ekker H, Galik B, Gyenesei A, Nagy G, Nagy E, Szijártó V. Mutti M, et al. Genome Announc. 2018 Feb 22;6(8):e00056-18. doi: 10.1128/genomeA.00056-18. Genome Announc. 2018. PMID: 29472331 Free PMC article.

7

Retained Activity of an O25b-Specific Monoclonal Antibody against an Mcr-1-Producing Escherichia coli Sequence Type 131 Strain.

Guachalla LM, Ramoni K, Varga C, Mutti M, Ghazawi A, Pál T, Nagy E, Sonnevend Á, Nagy G, Szijártó V. Guachalla LM, et al. Among authors: mutti m. Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00046-18. doi: 10.1128/AAC.00046-18. Print 2018 Jul. Antimicrob Agents Chemother. 2018. PMID: 29686149 Free PMC article.

8

Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature.

Mutti M, Cordella S, Parisotto A, Bettelli F, Morselli M, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Pioli V, Giusti D, Colaci E, Cassanelli L, Paolini A, Martinelli S, Maffei R, Riva G, Nasillo V, Sarti M, Trenti T, Comoli P, Tagliafico E, Manfredini R, Eccher A, Lagreca I, Barozzi P, Potenza L, Marasca R, Candoni A, Luppi M, Forghieri F. Mutti M, et al. Leuk Lymphoma. 2024 Apr;65(4):511-515. doi: 10.1080/10428194.2023.2294695. Epub 2023 Dec 19. Leuk Lymphoma. 2024. PMID: 38112426 Review. No abstract available.

9

BEhavioral Health Stratified Treatment (B.E.S.T.) to optimize transition to adulthood for youth with intellectual and/or developmental disabilities.

Berg KL, Mihaila I, Feinstein RT, Shiu CS, Gussin H, Acharya K, Gladstone TRG, Bernard L, Best M, Renz E, Abdallah G, Weldy S, Herrman D, Lynch E, Gerges M, Perez P, Buchholz KR, Msall M, Aaron S, Mutti M, Arnold C, Danguilan C, Argueta I, Hunter M, Pela E, Diviak K, Kuhn J, Berbaum ML, Van Voorhees BW. Berg KL, et al. Among authors: mutti m. Contemp Clin Trials. 2024 Jan;136:107374. doi: 10.1016/j.cct.2023.107374. Epub 2023 Oct 28. Contemp Clin Trials. 2024. PMID: 37898308 Clinical Trial.

10

Reduced prophylactic effect of tixagevimab-cilgavimab in patients with hematological malignancies and without antibody response after SARS-COV-2 vaccination.

Callegari C, Lazzarotto D, Soravia A, Mutti M, Lauzzana P, Peghin M, Cordella S, Fanin R, Candoni A. Callegari C, et al. Among authors: mutti m. Eur J Haematol. 2023 Oct;111(4):668-670. doi: 10.1111/ejh.14045. Epub 2023 Jul 18. Eur J Haematol. 2023. PMID: 37461815 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page